PRLD·74065P101·US·equity·Healthcare - Biotechnology-Activist
PRLD (PRELUDE THERAPEUTICS INC) is held by 38 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($34.6M), TWO SIGMA INVESTMENTS, LP ($3.2M), MILLENNIUM MANAGEMENT LLC ($1.3M). Net institutional sentiment: Mixed.
See how PRLD's score breaks down across 4 SEC sources
Showing 1-20 of 42
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer